Adenosine A2A receptor ligand recognition and signaling is blocked by A2B receptors

The adenosine receptor (AR) subtypes A2A and A2B are rhodopsin-like Gs protein-coupled receptors whose expression is highly regulated under pathological, e.g. hypoxic, ischemic and inflammatory conditions. Both receptors play important roles in inflammatory and neurodegenerative diseases, are blocked by caffeine, and have now become major drug targets in immuno-oncology. By Förster resonance energy transfer (FRET), bioluminescence resonance energy transfer (BRET), bimolecular fluorescence complementation (BiFC) and proximity ligation assays (PLA) we demonstrated A2A-A2BAR heteromeric complex formation. Moreover we observed a dramatically altered pharmacology of the A2AAR when co-expressed with the A2BAR (A2B ≥ A2A) in recombinant as well as in native cells. In the presence of A2BARs, A2A-selective ligands lost high affinity binding to A2AARs and displayed strongly reduced potency in cAMP accumulation and dynamic mass redistribution (DMR) assays. These results have major implications for the use of A2AAR ligands as drugs as they will fail to modulate the receptor in an A2A-A2B heteromer context. Accordingly, A2A-A2BAR heteromers represent novel pharmacological targets.

• Publication year

  2018

• Venue

  OncoTarget

• Publication date

  2018-02-06

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.18632/oncotarget.24423PMID 29568380PMCID 5862601
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methods used to study the oligomeric structure of G-protein-coupled receptors

  2017cited by this paper
• Quaternary structure of a G-protein-coupled receptor heterotetramer in complex with Gi and Gs

  2016cited by this paper
• Myeloid cells in the tumor microenvironment: Role of adenosine

  2016cited by this paper
• Adenosine Stimulate Proliferation and Migration in Triple Negative Breast Cancer Cells

  2016cited by this paper
• Role of extracellular cysteine residues in the adenosine A2A receptor

  2016influential reference
• Structure-guided development of heterodimer-selective GPCR ligands

  2016cited by this paper
• Role of adenosine A2b receptor overexpression in tumor progression.

  2016cited by this paper
• The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function

  2016cited by this paper
• Orexin–Corticotropin-Releasing Factor Receptor Heteromers in the Ventral Tegmental Area as Targets for Cocaine

  2015influential reference
• Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer

  2015cited by this paper
• Molecular expression of adenosine receptors in OVCAR-3, Caov-4 and SKOV-3 human ovarian cancer cell lines

  2015cited by this paper
• Dual agonist occupancy of AT1-R-α2C-AR heterodimers results in atypical Gs-PKA signaling.

  2015cited by this paper
• Proximity assays for sensitive quantification of proteins

  2015cited by this paper
• Adenosine activates brown adipose tissue and recruits beige adipocytes via A2A receptors

  2014cited by this paper
• NF-κB enhances hypoxia-driven T-cell immunosuppression via upregulation of adenosine A(2A) receptors.

  2014cited by this paper
• Adenosine A2A-D2 receptor-receptor interactions in putative heteromers in the regulation of the striato-pallidal gaba pathway: possible relevance for parkinson's disease and its treatment.

  2014cited by this paper
• BAY60-6583 Acts as a Partial Agonist at Adenosine A2B Receptors

  2014cited by this paper
• Probing biased/partial agonism at the G protein-coupled A(2B) adenosine receptor.

  2014cited by this paper
• Identification of Hypoxia-Inducible Factor HIF-1A as Transcriptional Regulator of the A2B Adenosine Receptor during Acute Lung Injury

  2014cited by this paper
• Adenosine receptors as drug targets — what are the challenges?

  2013cited by this paper
• Antiproliferative effects of selective adenosine receptor agonists and antagonists on human lymphocytes: evidence for receptor-independent mechanisms

  2013cited by this paper
• A2A adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients

  2013cited by this paper
• G protein-coupled receptor heterodimerization in the brain.

  2013cited by this paper
• Multiple sclerosis lymphocytes upregulate A2A adenosine receptors that are antiinflammatory when stimulated

  2013cited by this paper
• Adenosine A1 receptors heterodimerize with β1- and β2-adrenergic receptors creating novel receptor complexes with altered G protein coupling and signaling.

  2013cited by this paper
• The second extracellular loop of GPCRs determines subtype-selectivity and controls efficacy as evidenced by loop exchange study at A2 adenosine receptors.

  2013cited by this paper
• A2B adenosine receptor blockade inhibits growth of prostate cancer cells

  2013cited by this paper
• Regulation of lymphocyte function by adenosine.

  2012cited by this paper
• AT1R–CB1R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II

  2011cited by this paper
• Oligomerization of G protein-coupled receptors: computational methods.

  2011cited by this paper
• Adenosine A2A and A2B receptor expression in neuroendocrine tumours: potential targets for therapy

  2011cited by this paper
• Oligomerization of G protein-coupled receptors: biochemical and biophysical methods.

  2011cited by this paper
• Role of adenosine A(2B) receptors in inflammation.

  2011cited by this paper
• Adenosine and blood platelets

  2011cited by this paper
• Contributions of A2A and A2B adenosine receptors in coronary flow responses in relation to the KATP channel using A2B and A2A/2B double-knockout mice.

  2011cited by this paper
• Detection of antigen interactions ex vivo by proximity ligation assay: endogenous dopamine D2-adenosine A2A receptor complexes in the striatum.

  2011cited by this paper
• International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An Update

  2011cited by this paper
• The four cysteine residues in the second extracellular loop of the human adenosine A2B receptor: role in ligand binding and receptor function.

  2011cited by this paper
• Allosteric interactions across native adenosine-A3 receptor homodimers: quantification using single-cell ligand-binding kinetics

  2011cited by this paper
• Homogenization of mammalian tissue.

  2010cited by this paper
• Differential effects of adenosine A2a and A2b receptors on cardiac contractility.

  2010cited by this paper
• Adenosine A2A Receptor Is Involved in Cell Surface Expression of A2B Receptor*

  2010cited by this paper
• Characterization of the A2AR-D2R interface: focus on the role of the C-terminal tail and the transmembrane helices.

  2010cited by this paper
• HIF‐dependent induction of adenosine receptor A2b skews human dendritic cells to a Th2‐stimulating phenotype under hypoxia

  2010cited by this paper
• Building a new conceptual framework for receptor heteromers.

  2009cited by this paper
• 1-alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: development and characterization of adenosine A2B receptor antagonists and a new radioligand with subnanomolar affinity and subtype specificity.

  2009cited by this paper
• A quantitative protocol for dynamic measurements of protein interactions by Förster resonance energy transfer-sensitized fluorescence emission

  2009influential reference
• The Danger Signal Adenosine Induces Persistence of Chlamydial Infection through Stimulation of A2b Receptors

  2009influential reference
• Visualization of ternary complexes in living cells by using a BiFC-based FRET assay

  2008cited by this paper
• Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells

  2008cited by this paper
• Characterization of adenosine receptors in the human bladder carcinoma T24 cell line.

  2006cited by this paper
• Design and implementation of bimolecular fluorescence complementation (BiFC) assays for the visualization of protein interactions in living cells

  2006cited by this paper
• Human breast cancer cell line MDA‐MB‐231 expresses endogenous A2B adenosine receptors mediating a Ca2+ signal

  2005cited by this paper
• Hypoxia Modulates Adenosine Receptors in Human Endothelial and Smooth Muscle Cells Toward an A2B Angiogenic Phenotype

  2004cited by this paper
• Homodimerization of adenosine A2A receptors: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer

  2003cited by this paper
• Adenosine A2A-Dopamine D2 Receptor-Receptor Heteromerization

  2003influential reference
• Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation.

  2002cited by this paper
• Differential Expression of Adenosine Receptors in Human Endothelial Cells: Role of A2B Receptors in Angiogenic Factor Regulation

  2002cited by this paper
• International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors.

  2001cited by this paper
• Binding of [3H]MSX-2 (3-(3-hydroxypropyl)-7-methyl-8-(m-methoxystyryl)-1-propargylxanthine) to rat striatal membranes--a new, selective antagonist radioligand for A(2A) adenosine receptors.

  2000influential reference
• Protein determination by ponceau S using digital color image analysis of protein spots on nitrocellulose membranes.

  1999cited by this paper
• Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells.

  1999cited by this paper
• Pharmacological characterization of adenosine A2B receptors: studies in human mast cells co-expressing A2A and A2B adenosine receptor subtypes.

  1998cited by this paper
• An endogenous A2B adenosine receptor coupled to cyclic AMP generation in human embryonic kidney (HEK 293) cells

  1997cited by this paper
• Calcium mobilization in Jurkat cells via A2b adenosine receptors

  1997cited by this paper
• Comparative pharmacology of human adenosine receptor subtypes – characterization of stably transfected receptors in CHO cells

  1997cited by this paper
• Adenosine Receptor Antagonists: Structures and Potential Therapeutic Applications

  1996cited by this paper
• Functional characterization of adenosine A2 receptors in Jurkat cells and PC12 cells using adenosine receptor agonists

  1996cited by this paper
• G protein-dependent activation of phospholipase C by adenosine A3 receptors in rat brain.

  1995cited by this paper
• A2A adenosine receptors from rat striatum and rat pheochromocytoma PC12 cells: characterization with radioligand binding and by activation of adenylate cyclase.

  1992cited by this paper
• A modification of a protein-binding method for rapid quantification of cAMP in cell-culture supernatants and body fluid.

  1990cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Oncostatin M upregulates CD73 via the MAPK pathway in keratinocytes to promote an adenosine-dependent anti-inflammatory response in psoriasis.

  2026cites this paper
• Adenosine receptors on the immuno-oncology expressway: TIME, perspectives, and translation

  2026cites this paper
• Integrating Atom‐Based 3D‐QSAR, Molecular Docking, and Molecular Dynamics: A Multistep Approach for the Discovery of Potent Adenosine A2A Receptor Antagonists

  2025cites this paper
• Overexpression of adenosine receptor (A1, A2a, A2b, A3) genes in esophageal tumor tissue: A2b adenosine receptor as a potential biomarker and anticancer target.

  2025cites this paper
• The effect of oxidative stress on the adenosine A2A receptor activity and signalling.

  2025cites this paper
• Mitochondrial Localization and Function of Adenosine Receptors

  2025cites this paper
• Cannabinoid CB1 Receptor Activation Mitigates N‑Methyl‑d‑aspartate Receptor-Mediated Neurotoxicity.

  2025cites this paper
• Dual A2A/ A2B adenosine receptor antagonist M1069 counteracts immuno-suppressive mechanisms of adenosine and reduces tumor growth in vivo.

  2024cites this paper
• Comprehensive Review on Bimolecular Fluorescence Complementation and Its Application in Deciphering Protein–Protein Interactions in Cell Signaling Pathways

  2024cites this paper
• Caffeine Inhibits Both Basal and Insulin‐Activated Urate Transport

  2024influential citation
• The Expression and Functionality of CB1R-NMDAR Complexes Are Decreased in A Parkinson’s Disease Model

  2024cites this paper
• Exploring Biginelli-based scaffolds as A2B adenosine receptor antagonists: Unveiling novel structure-activity relationship trends, lead compounds, and potent colorectal anticancer agents.

  2024cites this paper
• Unveiling the complexity of G protein-coupled receptor heteromers: advances in live cell imaging technologies and biochemical methods

  2024cites this paper
• The Importance of the Immune System and Molecular Cell Signaling Pathways in the Pathogenesis and Progression of Lung Cancer

  2023cites this paper
• IL-6 in the infarcted heart is preferentially formed by fibroblasts and modulated by purinergic signaling

  2023cites this paper
• Adenosinergic Pathway in Parkinson’s Disease: Recent Advances and Therapeutic Perspective

  2023cites this paper
• The adenosine A2A receptor in the basal ganglia: Expression, heteromerization, functional selectivity and signalling.

  2023cites this paper
• Migraine signaling pathways: purine metabolites that regulate migraine and predispose migraineurs to headache

  2023cites this paper
• Impact of the selective A2AR and A2BR dual antagonist AB928/etrumadenant on CAR T cell function

  2022cites this paper
• Adenosine Targeting as a New Strategy to Decrease Glioblastoma Aggressiveness

  2022cites this paper
• Metabolic reprogramming by adenosine antagonism and implications in non-small cell lung cancer therapy

  2022cites this paper
• A2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models

  2022cites this paper
• Development of high-affinity fluorinated ligands for cannabinoid subtype 2 receptor, and in vitro evaluation of a radioactive tracer for imaging.

  2022cites this paper
• Expression of the Adenosine A2A-A3 Receptor Heteromer in Different Brain Regions and Marked Upregulation in the Microglia of the Transgenic APPSw,Ind Alzheimer’s Disease Model

  2022cites this paper
• Exploring the Effect of Halogenation in a Series of Potent and Selective A2B Adenosine Receptor Antagonists

  2022cites this paper
• Adenosine signalling in T‐cell activation favours development of IL‐17 positive cells with suppressive properties

  2022cites this paper
• Pharmacological Tuning of Adenosine Signal Nuances Underlying Heart Failure With Preserved Ejection Fraction

  2021cites this paper
• Methamphetamine Blocks Adenosine A2A Receptor Activation via Sigma 1 and Cannabinoid CB1 Receptors

  2021cites this paper
• Molecular and Pharmacological Characterization of the Interaction between Human Geranylgeranyltransferase Type I and Ras-Related Protein Rap1B

  2021cites this paper
• Purinergic GPCR transmembrane residues involved in ligand recognition and dimerization.

  2021cites this paper
• Adenosine Receptor Antagonists to Combat Cancer and to Boost Anti-Cancer Chemotherapy and Immunotherapy

  2021cites this paper
• Structure and function of adenosine receptor heteromers

  2021cites this paper
• A Cellular Assay for the Identification and Characterization of Connexin Gap Junction Modulators

  2021cites this paper
• The Old and New Visions of Biased Agonism Through the Prism of Adenosine Receptor Signaling and Receptor/Receptor and Receptor/Protein Interactions

  2021cites this paper
• The coming together of allosteric and phosphorylation mechanisms in the molecular integration of A2A heteroreceptor complexes in the dorsal and ventral striatal-pallidal GABA neurons

  2021cites this paper
• Novel Interactions Involving the Mas Receptor Show Potential of the Renin–Angiotensin system in the Regulation of Microglia Activation: Altered Expression in Parkinsonism and Dyskinesia

  2021cites this paper
• Release of adenosine-induced immunosuppression: Comprehensive characterization of dual A2A/A2B receptor antagonist.

  2021cites this paper
• Microglial Adenosine Receptors: From Preconditioning to Modulating the M1/M2 Balance in Activated Cells

  2021cites this paper
• Angiotensin AT1 and AT2 receptor heteromer expression in the hemilesioned rat model of Parkinson’s disease that increases with levodopa-induced dyskinesia

  2020cites this paper
• Melatonin and the control of intraocular pressure.

  2020cites this paper
• Agonists and Antagonists for Purinergic Receptors.

  2020cites this paper
• Adreno–melatonin receptor complexes control ion homeostasis and intraocular pressure ‐ their disruption contributes to hypertensive glaucoma

  2020cites this paper
• Expression of Melatonin and Dopamine D3 Receptor Heteromers in Eye Ciliary Body Epithelial Cells and Negative Correlation with Ocular Hypertension

  2020cites this paper
• Characteristics and the role of purinergic receptors in pathophysiology with focus on immune response

  2020cites this paper
• Multiple Adenosine-Dopamine (A2A-D2 Like) Heteroreceptor Complexes in the Brain and Their Role in Schizophrenia

  2020cites this paper
• Development of a Radiofluorinated Adenosine A2B Receptor Antagonist as Potential Ligand for PET Imaging

  2020cites this paper
• Adenosine A2A receptor antagonists: from caffeine to selective non‐xanthines

  2020cites this paper
• The adenosine pathway in immuno-oncology

  2020cites this paper
• A Nitrogen-Walk Approach to Explore Bioisosteric Replacements in a Series of Potent A2B Adenosine Receptor Antagonists.

  2020cites this paper
• Adenosine/A2B Receptor Signaling Ameliorates the Effects of Aging and Counteracts Obesity.

  2020cites this paper
• Adenosine A2A and A3 Receptors Are Able to Interact with Each Other. A Further Piece in the Puzzle of Adenosine Receptor-Mediated Signaling

  2020cites this paper
• Angiotensin AT1 and AT2 receptors heteromer expression in microglia correlates with Parkinson’s disease progression in the hemilesioned rat model of the disease

  2020cites this paper
• ArticleAdenosine A

  2020cites this paper
• Helmholtz-Zentrum Dresden-Rossendorf (HZDR) Radiosynthesis and in vivo evaluation of a fluorine-18 labeled pyrazine based radioligand for PET imaging of the adenosine A2B receptor

  2020cites this paper
• Specificity and nanomolar potency of melatonin on G-protein coupled melatonin MT1 and MT2 receptors expressed in HEK-293T human embryo kidney cells

  2019cites this paper
• A2A and A2B adenosine receptors: the extracellular loop 2 determines high (A2A) or low affinity (A2B) for adenosine.

  2019cites this paper
• An agonist radioligand for the proinflammatory lipid-activated G protein-coupled receptor GPR84 providing structural insights.

  2019cites this paper
• Expression of Adenosine Receptors in Rodent Pancreas

  2019cites this paper
• A2A Receptor Homodimer-Disrupting Sequence Efficiently Delivered by a Protease-Resistant, Cyclic CPP Vector

  2019cites this paper
• Label-free detection of transporter activity via GPCR signalling in living cells: A case for SLC29A1, the equilibrative nucleoside transporter 1

  2019cites this paper
• Can Allosteric Receptor-Protein Interactions in Receptor Complexes Be a Molecular Mechanism Involved in Cancer Immune Therapy?

  2019cites this paper
• On inotropic effects of UTP in the human heart

  2019cites this paper
• Generation and Function of Non-cell-bound CD73 in Inflammation

  2019cites this paper
• Luminescence- and Fluorescence-Based Complementation Assays to Screen for GPCR Oligomerization: Current State of the Art

  2019cites this paper
• Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function

  2019cites this paper
• A2bR-dependent signaling alters immune cell composition and enhances IL-6 formation in the ischemic heart.

  2019cites this paper
• Differential effect of amphetamine over the corticotropin-releasing factor CRF2 receptor, the orexin OX1 receptor and the CRF2-OX1 heteroreceptor complex.

  2019cites this paper
• Tinkering with targeting nucleotide signaling for control of intracellular Leishmania parasites.

  2019cites this paper
• A2B Adenosine Receptor Antagonists with Picomolar Potency.

  2019cites this paper
• The adenosine A2B G protein-coupled receptor: Recent advances and therapeutic implications.

  2019cites this paper
• Adenosine heteroreceptor complexes in the basal ganglia are implicated in Parkinson’s disease and its treatment

  2019cites this paper
• Identification of Heteroreceptors Complexes and Signal Transduction Events Using Bioluminescence Resonance Energy Transfer (BRET).

  2019cites this paper
• Adenosine Receptors as a Paradigm to Identify Dimer/Oligomers of G-Protein-Coupled Receptors and as Targets in Parkinson’s Disease and Schizophrenia

  2018cites this paper
• Biased receptor functionality versus biased agonism in G-protein-coupled receptors

  2018cites this paper
• Radiosynthesis and in vivo evaluation of a fluorine-18 labeled pyrazine based radioligand for PET imaging of the adenosine A2B receptor.

  2018cites this paper
• Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1–CB2 Heteroreceptor Complexes

  2018cites this paper
• Understanding the Role of Adenosine A2AR Heteroreceptor Complexes in Neurodegeneration and Neuroinflammation

  2018cites this paper
• G2A Protects Mice against Sepsis by Modulating Kupffer Cell Activation: Cooperativity with Adenosine Receptor 2b

  2018cites this paper
• A2AR-D2R Heteroreceptor Complexes in Cocaine Reward and Addiction.

  2018cites this paper
• Cannabidiol skews biased agonism at cannabinoid CB1 and CB2 receptors with smaller effect in CB1‐CB2 heteroreceptor complexes

  2018cites this paper
• N-Methyl-D-Aspartate Receptor Link to the MAP Kinase Pathway in Cortical and Hippocampal Neurons and Microglia Is Dependent on Calcium Sensors and Is Blocked by α-Synuclein, Tau, and Phospho-Tau in Non-transgenic and Transgenic APPSw,Ind Mice

  2018cites this paper
• Medicinal chemistry of a2B adenosine receptors

  2018cites this paper
• Tritium-labeled agonists as tools for studying adenosine A2B receptors

  2018cites this paper
• Fluorescent-Labeled Selective Adenosine A2B Receptor Antagonist Enables Competition Binding Assay by Flow Cytometry.

  2018cites this paper
• Research Progress of GPR171

  year unknowncites this paper